- Extraordinary images show one of fundamental processes of life
- Mechanism goes into overdrive in cancer - and could be target for new drugs
Scientists have unveiled incredible images of how the DNA code is read and interpreted - revealing new detail about one of the fundamental processes of life.
The mechanism for reading DNA and decoding it to build proteins for their needs is common to all animals and plants, and is often hijacked by cancer.
Researchers used an advanced form of electron microscopy called Cryo-EM, for which the Nobel Prize in Chemistry was awarded in 2017, to zoom in and capture images of the reading mechanism in unprecedented detail.
The discovery of exactly how the molecular mechanism works - published in the journal Nature - could open up new approaches to cancer treatment.
Scientists at The Institute of Cancer Research, London, captured images of molecular machinery called RNA Polymerase III in the act of transcribing a gene in exquisite and unprecedented detail.
The work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC), Cancer Research UK and the Wellcome Trust.
RNA polymerase III is crucial to life for all eukaryotic cells - including all animals and plants. In cancer, it is more active, causing cells to produce larger numbers of the building blocks they need to grow and multiply.
Cryo-EM is so powerful that it can take pictures of tiny molecules - approximately 5 nanometers or 20000th of the width of a human hair - at almost an atomic level.
It allowed researchers to see for the first time how components of the RNA polymerase III complex and accessory molecules interact and communicate with each other, suggesting how drugs might be employed to split the complex up.
The new study captured the molecular machinery in the act of binding to DNA, separating the two strands and getting ready to transcribe the DNA code.
Cryo-EM involves freezing and imaging samples at -180°C to preserve minute details of protein shapes. This type of microscopy is also an emerging and exciting approach in cancer drug design.
Scientists at The Institute of Cancer Research (ICR) used the technique to reveal five key stages in which the complex reshapes itself to successfully transcribe the DNA code. Each of these stages could potentially become the target of new cancer drugs.
The researchers looked at the molecular mechanism in yeast cells, but the same machinery is used in humans.
The complex reads the DNA code and makes material known as transfer RNA - an essential part of producing the protein building blocks needed to allow cells to grow or to make new cells.
Cancer cells need large numbers of these protein building blocks as they rapidly grow and divide, so they can become particularly reliant on components of the RNA polymerase III complex.
Dr Alessandro Vannini, Team Leader in Structural Biology at The Institute of Cancer Research, London, said:
"We used a really exciting new type of microscopy called Cryo-EM to do something no scientists have been able to do before. We were able to freeze and catch the RNA polymerase III complex in the act of attaching to, separating and reading the DNA code. We obtained almost a million of independent snapshots and, using powerful computers we grouped similar snapshots together, enhancing their detail to obtain a vivid reconstruction of this machinery at work."
"Now we know how the components of this crucial molecular mechanism fit together, we may be able to design drugs that turn the system on or off - and these could offer a whole new way of treating cancer."
Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, said:
"Cryo-EM is revolutionising molecular and cellular biology, allowing us to look in minute detail at molecular machines within cells and how they work. The technique is helping scientists to discover weaknesses in cancer cells that could be targeted by the next generation of drugs.
"This beautiful study has unveiled a fundamental cog in the inner workings of cells, and one that is often exploited by cancers. It's a hugely important finding in cell biology, and I hope that in future it will lead to new treatments for cancer patients."
Dr Amanda Collis, interim Executive Director of Science at BBSRC, said:
"Cryo-EM is rapidly advancing our knowledge of the structure and behaviour of biological molecules, and this exciting discovery demonstrates how fundamental understanding of biological systems can open the door to the development of potential new cancer therapies."
Universities and Science Minister Sam Gyimah said:
"This incredible new advancement in DNA decoding will further our understanding of disease, potentially leading to vital lifesaving treatment, including new ways to tackle cancer.
"The recently published Life Sciences Sector Deal, through our Industrial Strategy, will pave the way for more investment in innovative new treatments and technologies that will not only improve patient lives, but also drive economic growth making Britain fit for the future."
Images, animation and video are available on request.
For more information please contact Claire Hastings in the ICR press office on 020 7153 5380 or email@example.com. For enquiries out of hours, please call 07595 963 613.
Notes to editors
The Institute of Cancer Research, London, is one of the world's most influential cancer research organisations.
Scientists and clinicians at The Institute of Cancer Research (ICR) are working every day to make a real impact on cancer patients' lives. Through its unique partnership with The Royal Marsden NHS Foundation Trust and 'bench-to-bedside' approach, the ICR is able to create and deliver results in a way that other institutions cannot. Together the two organisations are rated in the top four centres for cancer research and treatment globally.
The ICR has an outstanding record of achievement dating back more than 100 years. It provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today it is a world leader at identifying cancer-related genes and discovering new targeted drugs for personalised cancer treatment.
A college of the University of London, the ICR is the UK's top-ranked academic institution for research quality, and provides postgraduate higher education of international distinction. It has charitable status and relies on support from partner organisations, charities and the general public.
The ICR's mission is to make the discoveries that defeat cancer. For more information visit http://www.icr.ac.uk